Antibiotic Associated Diarrhea

← Back to Index (

Pathophysiology

Etiologic Agents

Category Pathogens
Most Common Clostridioides difficile (C. difficile).
Other Organisms Staphylococcus, Candida, Enterobacteriaceae, Klebsiella.

Clinical Manifestations

Diagnostic Evaluation

Investigation Utility And Interpretation
Target Population Testing discouraged in children <2 years due to high asymptomatic carriage.
Stool Assays Multistep approach recommended combining glutamate dehydrogenase (GDH) immunoassay, toxin A/B enzyme immunoassay (EIA), and nucleic acid amplification tests (NAAT).
Endoscopy Indicated for suspected pseudomembranous colitis. Reveals 2-5 mm raised yellowish plaques on colonic mucosa.

Management Protocol

Pharmacotherapy For C. difficile

Severity/Scenario Drug Choice And Dosage
First-Line (Mild-Moderate) Oral Metronidazole 30 mg/kg/day in 4 divided doses for 7-10 days.
Severe/Refractory Disease Oral Vancomycin 40 mg/kg/day in 4 divided doses (maximum 2 g/day) for 10-14 days.
Alternative Therapy Fidaxomicin approved for children >6 months; efficacy equivalent to vancomycin.
Recurrent Disease Pulsed-tapered oral vancomycin regimen over 4-6 weeks. Fecal microbiota transplantation utilized for multiply recurrent cases.

Prevention Strategies